Evidence map›Paper›PMID 37515168›Full record

ArticleViruses2023

The 2022 West Nile Virus Season in Greece; A Quite Intense Season.

Danai Pervanidou, Chrysovaladou Niki Kefaloudi, Anna Vakali, Ourania Tsakalidou, Myrsini Karatheodorou, Katerina Tsioka, Maria Evangelidou, Kassiani Mellou, Styliani Pappa, Konstantina Stoikou and 7 more

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Increased incidence of human West Nile and Usutu infections in Austria, 2024: analysis of data from 2009 to 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Seroprevalence of West Nile virus, Greece, 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. The European Union One Health 2023 Zoonoses report.EFSA journal. European Food Safety Authority · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The European Union One Health 2022 Zoonoses Report.EFSA journal. European Food Safety Authority · 2023
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Danai PervanidouNational Public Health Organization (EODY), 151 23 Athens, Greece.
Chrysovaladou Niki KefaloudiNational Public Health Organization (EODY), 151 23 Athens, Greece.
Anna VakaliNational Public Health Organization (EODY), 151 23 Athens, Greece.ORCID 0009-0000-5635-9520
Ourania TsakalidouNational Reference Center for Arboviruses and Haemorrhagic Fever Viruses, Department of Microbiology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
Myrsini KaratheodorouNational Reference Center for Arboviruses and Haemorrhagic Fever Viruses, Department of Microbiology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
Katerina TsiokaNational Reference Center for Arboviruses and Haemorrhagic Fever Viruses, Department of Microbiology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0001-5200-8045
Maria EvangelidouHellenic Pasteur Institute, 115 21 Athens, Greece.
Kassiani MellouNational Public Health Organization (EODY), 151 23 Athens, Greece.ORCID 0000-0002-0065-5766
Styliani PappaNational Reference Center for Arboviruses and Haemorrhagic Fever Viruses, Department of Microbiology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
Konstantina StoikouNational Reference Center for Arboviruses and Haemorrhagic Fever Viruses, Department of Microbiology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.
Vasiliki BakaloudiMolecular Blood Center, AHEPA University General Hospital, 546 36 Thessaloniki, Greece.
George KoliopoulosDepartment of Crop Science, School of Plant Sciences, Agricultural University of Athens, 118 55 Athens, Greece.
Kostas StamoulisHellenic National Blood Transfusion Center, 136 72 Athens, Greece.
Eleni PatsoulaDepartment of Public Health Policy, School of Public Health, University of West Attica, 115 21 Athens, Greece.
Constantina PolitisNational Public Health Organization (EODY), 151 23 Athens, Greece.
Christos HadjichristodoulouDepartment of Hygiene and Epidemiology, School of Health Sciences, Faculty of Medicine, University of Thessaly, 412 22 Larisa, Greece.ORCID 0000-0002-4769-8376
Anna PapaNational Reference Center for Arboviruses and Haemorrhagic Fever Viruses, Department of Microbiology, Medical School, Faculty of Health Sciences, Aristotle University of Thessaloniki, 541 24 Thessaloniki, Greece.ORCID 0000-0002-6643-3322

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since 2010, the West Nile virus (WNV) has been established in Greece. We describe the epidemiology of diagnosed human WNV infections in Greece with a focus on the 2022 season. During the transmission period, clinicians were sending samples from suspected cases for testing. Active laboratory-based surveillance was performed with immediate notification of diagnosed cases. We collected clinical information and interviewed patients on a timely basis to identify their place of exposure. Besides serological and molecular diagnostic methods, next-generation sequencing was also performed. In 2022, 286 cases of WNV infection were diagnosed, including 278 symptomatic cases and 184 (64%) cases with neuroinvasive disease (WNND); 33 patients died. This was the third most intense season concerning the number of WNND cases, following 2018 and 2010. Most (96%) cases were recorded in two regions, in northern and central Greece. The virus strain was a variant of previous years, clustering into the Central European subclade of WNV lineage 2. The 2022 WNV season was quite intense in Greece. The prompt diagnosis and investigation of cases are considered pivotal for the timely response, while the availability of whole genome sequences enables studies on the molecular epidemiology of the disease.

Indexed as

West Nile FeverWest Nile virusDisease OutbreaksGreeceHumansSeasonsGreecemosquito-borne diseasevector-borne diseaseWest Nile virus

Identifiers

PMID37515168
PMCPMC10383024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.